Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
Carol M Ulloa, Allen Towfigh, Joseph SafdiehDepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USAAbstract: Levetiracetam is a second-generation antiepileptic drug (AED) with a unique chemical structure and mechanism of action. The extended release f...
Enregistré dans:
Auteurs principaux: | Carol M Ulloa, Allen Towfigh, Joseph Safdieh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e44f6df13ed84c11b8e7bb96312495c7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
par: Cormier J, et autres
Publié: (2013) -
Monotherapy for partial epilepsy: focus on levetiracetam
par: Antonio Gambardella, et autres
Publié: (2008) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
par: Anna Kelemen, et autres
Publié: (2010) -
Profile of perampanel and its potential in the treatment of partial onset seizures
par: Rheims S, et autres
Publié: (2013) -
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
par: Weisenberg JLZ, et autres
Publié: (2011)